Medmix
Medmix AG, headquartered in Switzerland (CH), is a leading player in the precision dispensing and mixing solutions industry. Founded in 2021, the company emerged from a rich heritage of innovation, focusing on advanced technologies for the healthcare, consumer, and industrial sectors. With a strong presence in Europe, Asia, and the Americas, Medmix offers a diverse range of core products, including high-performance dispensing systems and mixing solutions that stand out for their reliability and efficiency. The company is recognised for its commitment to quality and sustainability, positioning itself as a trusted partner in various markets. Medmix has quickly established itself as a key competitor, leveraging its expertise to deliver tailored solutions that meet the evolving needs of its clients, thereby solidifying its reputation in the global marketplace.
DitchCarbon Score
How does Medmix's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medmix's score of 69 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medmix's reported carbon emissions
In 2024, Medmix reported total carbon emissions of approximately 73,000,000 kg CO2e, comprising 4,351,000 kg CO2e from Scope 1, 5,880,000 kg CO2e from Scope 2, and 63,355,000 kg CO2e from Scope 3. This reflects a slight decrease in Scope 1 emissions from 4,381,000 kg CO2e in 2023, while Scope 2 emissions increased from 1,214,000 kg CO2e in 2023. Scope 3 emissions also rose from 60,044,000 kg CO2e in 2023. Medmix has set ambitious climate commitments, aiming for net-zero greenhouse gas emissions across its entire value chain by 2050. The company has established near-term targets to reduce absolute Scope 1 and 2 emissions by 80% by 2029, based on a 2019 baseline. Additionally, Medmix aims to cut Scope 3 emissions by 42% within the same timeframe. Long-term, the company targets a 90% reduction in all scopes by 2050. These commitments align with the Science Based Targets initiative (SBTi) and reflect Medmix's dedication to addressing climate change and reducing its carbon footprint.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 5,408,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 1,545,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 67,803,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medmix is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
